131.500

+0.310 (+0.24%)
Range 130.650 - 131.740   (0.83%)
Open 130.810
Previous Close 131.190
Bid Price 55.480
Bid Volume -
Ask Price 55.490
Ask Volume -
Volume 1,487,202
Value -
Remark
Delayed prices. Updated at 21 May 2024 00:26.
Data powered by
View All Events

About MERCK & CO INC

Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. On July 2, 2014, Santen Pharmaceutical Co., Ltd acquired certain ophthalmology assets from Merck & Co., Inc. On August 5, 2014, Merck & Co Inc (Merck) acquired Idenix Pharmaceuticals Inc (Idenix).

There are 13 followers

Followers
0
Followers
0
FOUNDER, SGSTOCKSINVESTING.COM
Followers
758
Followers
0
Followers
0
LLM
Followers
1
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
2
Followers
0